| Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer (NCT06007092) | Gustave Roussy, Cancer Campus, Grand Paris | 2023-07-31 |
| Neural and Physiological Correlates of Psychedelic Sub-states (NCT05698511) | Robin Carhart-Harris, PhD, MA | 2023-07-31 |
| Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers (NCT05547464) | BioNTech SE | 2023-07-31 |
| Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants (NCT05932641) | AstraZeneca | 2023-07-31 |
| Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients with EGFR or HER2 Mutant Advanced Non-small Cell Lung Cancer (WU-KONG19) (NCT05926180) | Dizal Pharmaceuticals | 2023-07-31 |
| A Study of Tirzepatide (LY3298176) in Healthy Lactating Females (NCT05978713) | Eli Lilly and Company | 2023-07-31 |
| A Study to Learn About the Tastes of Different Suspensions With the Study Medicine (PF-07923568) in Healthy Adult Participants. (NCT06003829) | Pfizer | 2023-07-31 |
| JYB1907 in Subjects With Advanced Solid Tumors (NCT05821595) | Jemincare | 2023-07-31 |
| A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC (NCT05394831) | J Ints Bio | 2023-07-30 |
| Bioequivalence Study of Empagliflozin 25 mg Film Coated Tablets of Humanis, Turkey and Jardiance (Empagliflozin) 25 mg Film-coated Tablets of Boehringer Ingelheim International GmbH, Germany in Normal, Healthy, Adult, Human Subjects Under Fasting Condition (NCT06180109) | Humanis Saglık Anonim Sirketi | 2023-07-30 |
| Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia (NCT05964790) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2023-07-30 |
| Safety of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Decompensated Hepatitis B Cirrhosis (NCT05948982) | Asia Cell Therapeutics (Shanghai) Co., Ltd. | 2023-07-30 |
| Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring (NCT05994599) | Evestra Inc. | 2023-07-29 |
| A Study of XmAb®662 as Monotherapy or in Combination With Pembrolizumab in Advanced Solid Tumors (NCT05996445) | Xencor, Inc. | 2023-07-28 |
| Galunisertib Combined With Capecitabine in Advanced CRC With PM (NCT05700656) | The Netherlands Cancer Institute | 2023-07-28 |
| A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors (NCT05954312) | Vividion Therapeutics, Inc. | 2023-07-28 |
| A Study in Subjects With Liver Function Injury and Subjects With Normal Liver Function (NCT06093230) | Shanghai Vinnerna Biosciences Co., Ltd. | 2023-07-28 |
| Parsaclisib in Patients With Relapsed or Refractory Follicular Lymphoma (NCT05867030) | Innovent Biologics (Suzhou) Co. Ltd. | 2023-07-28 |
| Dog-rose, Cranberry Leaves, Cranberry Berries, Alfalfa, Fenugreek, Lemon Beebrush, Urtica and Sumac in Diabetes Mellitus (NCT05700513) | Tabriz University of Medical Sciences | 2023-07-28 |
| Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma (NCT04977167) | HitGen Inc. | 2023-07-28 |
| A Study to Investigate Effect of Clarithromycin, a Strong CYP3A4 Inhibitor, on Brensocatib Pharmacokinetics in Healthy Participants (NCT05965570) | Insmed Incorporated | 2023-07-28 |
| A Study of IBI363 in Combination With Bevacizumab or Furuitinib in Subjects With Advanced Colorectal Cancer (NCT06717880) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2023-07-28 |
| A Study to Evaluate the Pharmacokinetics and Safety of Loncastuximab Tesirine in Participants With Relapsed or Refractory Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma With Hepatic Impairment (LOTIS-10) (NCT05660395) | ADC Therapeutics S.A. | 2023-07-28 |
| Study of Single and Multiple Ascending Doses of ZE46-0134 in Healthy Volunteers (NCT06399315) | Lomond Therapeutics Holdings, Inc. | 2023-07-28 |
| BBP-398 in Combination With Osimertinib in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutations (NCT06032936) | LianBio LLC | 2023-07-27 |
| XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. (NCT06792435) | Astellas Pharma Global Development, Inc. | 2023-07-27 |
| Lurbinectedin in FET-Fused Tumors (NCT05918640) | Children's Hospital of Philadelphia | 2023-07-27 |
| A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants (NCT05906836) | Eli Lilly and Company | 2023-07-27 |
| A Study of TXN10128 in Subjects With Solid Tumors (NCT05978492) | Txinno Bioscience Inc. | 2023-07-27 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 in Japanese and Chinese Healthy Volunteers.. (NCT05955183) | AstraZeneca | 2023-07-27 |
| Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic Dermatitis (NCT06009094) | Jiangsu vcare pharmaceutical technology co., LTD | 2023-07-27 |
| TSN222 in Subjects With Advanced Solid Tumors or Lymphomas (NCT05842785) | Tyligand Bioscience (Shanghai) Limited | 2023-07-26 |
| A Phase 1 Study of BMF-500 in Adults With Acute Leukemia (NCT05918692) | Biomea Fusion Inc. | 2023-07-26 |
| Single Ascending Oral Dose Study to Investigate the Effects of OCT461201 in Healthy Volunteers (NCT06398925) | Oxford Cannabinoid Technologies Holdings PLC | 2023-07-26 |
| A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age (NCT05975099) | ModernaTX, Inc. | 2023-07-26 |
| Study of 64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors (NCT05930457) | The First Affiliated Hospital of Guangzhou Medical University | 2023-07-26 |
| Effect of Acetaminophen Preemptive Analgesia on Postoperative Cognitive Function (NCT06004687) | Affiliated Hospital of Nantong University | 2023-07-26 |
| A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A (NCT06185335) | Biocad | 2023-07-26 |
| DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer (NCT05680922) | Legend Biotech USA Inc | 2023-07-26 |
| Phase II Clinical Clical of the Pure Protein Derivatives of BCG (NCT06975774) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2023-07-26 |
| Evaluation of the Pharmacokinetics, Safety, and Tolerability of IM Letrozole LEBE in Healthy Post-menopausal Women (NCT06315205) | Rovi Pharmaceuticals Laboratories | 2023-07-26 |
| Interoception and Body Scan (NCT06237530) | University of Valencia | 2023-07-26 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Immunogenicity of 9MW3811 in Healthy Subjects (NCT05912049) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2023-07-26 |
| Savolitinib Plus Docetaxel as 2L in EGFR/ALK/ROS1/MET ex14m-wildtype NSCLC With MET Overexpression (NCT05777278) | The First Affiliated Hospital of Guangzhou Medical University | 2023-07-26 |
| A Study to Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy (NCT05612178) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-07-26 |
| Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLL (NCT05963217) | University Health Network, Toronto | 2023-07-26 |
| Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and Camlipixant (NCT05959447) | Bellus Health Inc. - a GSK company | 2023-07-26 |
| A Study of EOC237 in Patients With Advanced Solid Tumor (NCT05895825) | Shanghai Yiteng Jingang Bio-pharmaceutical Technology Co., Ltd | 2023-07-26 |
| Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease (NCT04289571) | National Eye Institute (NEI) | 2023-07-25 |
| A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression. (NCT05845138) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2023-07-25 |
| A Study of Maribavir Pediatric Formulation in Healthy Adult Participants (NCT05918822) | Takeda | 2023-07-25 |
| AMT-116 in Patients With Advanced Solid Tumors (NCT05725291) | Multitude Therapeutics Inc. | 2023-07-25 |
| STA363 in the Treatment of Lumbar Disc Herniation (NCT06022263) | Stayble Therapeutics | 2023-07-25 |
| Study of the Selective GlyT1 Inhibitor Bitopertin for Steroid-Refractory Diamond-Blackfan Anemia (NCT05828108) | National Heart, Lung, and Blood Institute (NHLBI) | 2023-07-25 |
| Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy (NCT04691817) | Abramson Cancer Center at Penn Medicine | 2023-07-25 |
| IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma (NCT05353530) | University of Florida | 2023-07-25 |
| A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies (NCT05955105) | Innolake Biopharm | 2023-07-25 |
| A Study in Healthy Men to Test How Different Doses of BI 3000202 Are Tolerated and How Food Influences the Amount of BI 3000202 in the Blood (NCT05945888) | Boehringer Ingelheim | 2023-07-25 |
| A Study of the Effect of Efavirenz on the Plasma Levels of Nemtabrutinib (MK-1026-014) (NCT06698016) | Merck Sharp & Dohme LLC | 2023-07-25 |
| A Study to Evaluate the Effect of Food on Nemtabrutinib (MK-1026) in Healthy Participants (MK-1026-016) (NCT06772805) | Merck Sharp & Dohme LLC | 2023-07-24 |
| A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies (NCT05473156) | AP Biosciences Inc. | 2023-07-24 |
| A Study of EXG102-031 in Patients With wAMD (Everest) (NCT05903794) | Exegenesis Bio | 2023-07-24 |
| Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC (NCT07136285) | Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd. | 2023-07-24 |
| Safety, Tolerability, and Pharmacokinetics of DD-S052P in Healthy Volunteers (NCT07347223) | HLB Science | 2023-07-24 |
| Washed Microbiota Transplantation for Chronic Constipation in Adults (NCT06106685) | The Second Hospital of Nanjing Medical University | 2023-07-24 |
| Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein SOSIP v8.2 763 Vaccine, Adjuvanted With MPLA Liposomes, in Healthy, HIV-Uninfected Adults (NCT05772286) | Fundacion Clinic per a la Recerca Biomédica | 2023-07-24 |
| A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors (NCT05859464) | Zai Lab (Hong Kong), Ltd. | 2023-07-24 |
| Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma (NCT05879367) | Orbus Therapeutics, Inc. | 2023-07-24 |
| Pharmacokinetic Parameters of Stiripentol in Renal Impaired Patients and Matching Controls With Normal Renal Function (NCT05735951) | Biocodex | 2023-07-24 |
| A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors (NCT05836324) | Incyte Corporation | 2023-07-24 |
| A Study to Evaluate Pharmacokinetic and Safety Trial of Emraclidine in Participants With Renal Impairment Compared With Participants With Normal Renal Function (NCT05940402) | AbbVie | 2023-07-24 |
| [14C] Study to Investigate the Mass Balance and Biotransformation of WPV01 in Healthy Adult Chinese Male Participants (NCT07080658) | Westlake Pharmaceuticals (Hangzhou) Co., Ltd. | 2023-07-23 |
| Safety, Tolerability, and Immunogenicity of Recombinant Meningococcal Group B Vaccine (E.Coli) (NCT06314880) | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 2023-07-22 |
| Tissue Inhibitor of Metalloproteinases 2 Level in Patients Undergoing Cardiac Surgery (NCT06871826) | Wuhan University | 2023-07-22 |
| A Study to Evaluate Drug-drug Interactions and Safety Between "BR3006-1", "BR3006-2", and "BR3006-3" in Healthy Volunteers (NCT05951946) | Boryung Pharmaceutical Co., Ltd | 2023-07-22 |
| Study of MAR001 in Adults With Metabolic Dysfunction (NCT05896254) | Marea Therapeutics | 2023-07-22 |
| Base Edited CAR T Cells Against AML: Deep Conditioning Ahead of Allogeneic Stem Cell Transplantation (NCT05942599) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2023-07-21 |
| AVT03 With Xgeva in Healthy Male Subjects (NCT05876949) | Alvotech Swiss AG | 2023-07-21 |
| A Study in Healthy Japanese Men to Test How Well Different Doses of BI 765845 Are Tolerated (NCT06139341) | Boehringer Ingelheim | 2023-07-21 |
| A Relative Bioavailability Study of Peresolimab (LY3462817) Formulations in Healthy Participants (NCT05959109) | Eli Lilly and Company | 2023-07-21 |
| A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7 (NCT05958199) | NextPoint Therapeutics, Inc. | 2023-07-21 |
| A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid Tumors (NCT05940116) | Hansoh BioMedical R&D Company | 2023-07-20 |
| AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1) (NCT05850234) | AstraZeneca | 2023-07-20 |
| The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias (NCT05756322) | Lin BioScience, Inc | 2023-07-20 |
| Study, Evaluating Pharmacokinetics, Immunogenicity and Safety Profiles of Pertuzumab Compared to Perjeta® in Healthy Man (NCT05825781) | Mabscale, LLC | 2023-07-20 |
| Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Renal Impairment Study (MK-0616-020) (NCT05934292) | Merck Sharp & Dohme LLC | 2023-07-20 |
| Genetically Modified Cells (KIND T Cells) for the Treatment of HLA-A*0201-Positive Patients With H3.3K27M-Mutated Glioma (NCT05478837) | University of California, San Francisco | 2023-07-20 |
| A Clinical Trial of CS12192 in Healthy Subjects (NCT05922709) | Chipscreen Biosciences, Ltd. | 2023-07-20 |
| Study of VEGF-A Targeting NIR-II Fluorescence Endoscopy in the Gastrointestinal Tract (NCT06430372) | Institute of Automation, Chinese Academy of Sciences | 2023-07-20 |
| Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration (NCT05953012) | PharmAbcine | 2023-07-20 |
| Effects of Repeated Psilocybin Dosing in OCD (NCT05370911) | Yale University | 2023-07-20 |
| A Study Evaluating the Relative Bioavailability and Food Effect of a Tablet Formulation of VX-147 (NCT05955872) | Vertex Pharmaceuticals Incorporated | 2023-07-19 |
| Assessment of the Safety and Efficacy of C019199 Plus Sintilimab in Participants With Advanced Solid Tumors (NCT06220318) | Fujian Haixi Pharmaceuticals Co., Ltd. | 2023-07-19 |
| A Study Evaluating the Pharmacokinetics and Relative Bioavailability of Emraclidine Immediate-Release Tablets in Healthy Adult Participants (NCT05933187) | Cerevel Therapeutics, LLC | 2023-07-19 |
| A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours (NCT05804526) | RemeGen Co., Ltd. | 2023-07-19 |
| Study of ZGGS15 in Patients With Advanced Solid Tumors (NCT05864573) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2023-07-19 |
| PRISM Race and Communication Pilot RCT (NCT04915079) | University of Washington | 2023-07-19 |
| A Study of BGB-30813 Alone or in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors (NCT05904496) | BeiGene | 2023-07-19 |
| A Phase I Study of SHR -2001 in Healthy Subjects (NCT05942612) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2023-07-19 |
| MIrabegron and Physiological Function in Cold Environments (NCT05990387) | Indiana University | 2023-07-19 |